AVONHURST ADVISES LIMERSTON CAPITAL ON ITS ACQUISTION

Avonhurst has advised Limerston Capital on its acquisition of the microbiology and testing business of Wickham Laboratories and establishment of Wickham Micro. Corporate partner Emmanuel Amos led the Avonhurst team, supported by senior associate Joshua Swerner.

Wickham Micro specialises in GMP/GLP compliant contract testing in the UK in the pharmaceuticals and medical device sectors. As part of this transaction, the owners of Wickham Laboratories have retained the (in vivo) toxicity business.

Emmanuel Amos, Corporate partner, comments:

“We are proud to have advised Limerston Capital on this recent acquisition and look forward to seeing Wickham Micro’s continued growth in the pharmaceutical and medical device testing markets, led by its first class management team.”